|
EMMPRIN/CD147 as a novel independent prognostic biomarker in melanoma. |
|
|
Travel, Accommodations, Expenses - Bristol-Myers Squibb |
|
|
Consulting or Advisory Role - Roche Pharma AG |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis |
Travel, Accommodations, Expenses - Roche |
|
|
Honoraria - Roche Pharma AG |
Consulting or Advisory Role - GlaxoSmithKline; Novartis; Roche Pharma AG |